Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1989;67(1):51–58.

Malaria prophylaxis with proguanil and sulfisoxazole in children living in a malaria endemic area.

L W Pang, N Limsomwong, P Singharaj, C J Canfield
PMCID: PMC2491212  PMID: 2706727

Abstract

The effects of three separate antimalarial prophylactic regimens (proguanil, sulfisoxazole, and proguanil plus sulfisoxazole) and of vitamins in a control group were compared in a study population of 380 children living in a malaria endemic area along the Thai-Burmese border. The subjects, aged 5-16 years, were matched for age, weight, and presence of splenomegaly, then randomly assigned to one of the four groups. All medications were administered daily by the investigators and malaria smears were performed on a weekly basis. Among 99 subjects taking proguanil plus sulfisoxazole for a total of 1464 man-weeks, there was only one case of falciparum and no vivax malaria. Statistically, this regimen proved superior to each of the other groups against both Plasmodium falciparum and P. vivax. The data show that proguanil alone, as a causal or suppressive prophylatic, has poor efficacy against P. falciparum. Side-effects were infrequent and generally mild, except for two subjects whose sulfisoxazole prophylaxis was discontinued because of urticarial rash.

Full text

PDF
51

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Black R. H. Malaria in the Australian army in South Vietnam: successful use of a proguanil-dapsone combination for chemoprophylaxis of chloroquine-resistant falciparum malaria. Med J Aust. 1973 Jun 30;1(26):1265–1270. doi: 10.5694/j.1326-5377.1973.tb111114.x. [DOI] [PubMed] [Google Scholar]
  2. Bourke A. T., Puhomchareon S., Cadigan F. C., Gould D. J., Pinswasdi K. Prevalence of malaria exhibiting reduced sensitivity to chloroquine in Southern Thailand. Trans R Soc Trop Med Hyg. 1966;60(2):225–230. doi: 10.1016/0035-9203(66)90031-9. [DOI] [PubMed] [Google Scholar]
  3. Cadigan F. C., Jr, Sadudee N., Bourke A. T., Gould D. J., Winter P. E. Surveys on chloroquine resistant P. falciparum in Thailand. Trans R Soc Trop Med Hyg. 1968;62(4):562–566. doi: 10.1016/0035-9203(68)90145-4. [DOI] [PubMed] [Google Scholar]
  4. Centers for Disease Control (CDC) Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum. MMWR Morb Mortal Wkly Rep. 1985 Apr 12;34(14):185-90, 195. [PubMed] [Google Scholar]
  5. Clyde D. F., Miller R. M., DuPont H. L., Hornick R. B. Treatment of falciparum malaria caused by strain resistant to quinine. JAMA. 1970 Sep 21;213(12):2041–2045. [PubMed] [Google Scholar]
  6. Cook G. C. Prevention and treatment of malaria. Lancet. 1988 Jan 2;1(8575-6):32–37. doi: 10.1016/s0140-6736(88)91012-4. [DOI] [PubMed] [Google Scholar]
  7. Dixon K. E., Williams R. G., Pongsupat T., Pitaktong U., Phintuyothin P. A comparative trial of Mefloquine and Fansidar in the treatment of falciparum malaria: failure of Fansidar. Trans R Soc Trop Med Hyg. 1982;76(5):664–667. doi: 10.1016/0035-9203(82)90238-3. [DOI] [PubMed] [Google Scholar]
  8. EDESON J. F. B., FIELD J. W. Proguanil-resistant falciparum malaria in Malaya. Br Med J. 1950 Jan 21;1(4646):147–151. doi: 10.1136/bmj.1.4646.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hurwitz E. S., Johnson D., Campbell C. C. Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand. Lancet. 1981 May 16;1(8229):1068–1070. doi: 10.1016/s0140-6736(81)92239-x. [DOI] [PubMed] [Google Scholar]
  10. Liston T. E., Foshee W. S., Pierson W. D. Sulfisoxazole chemoprophylaxis for frequent otitis media. Pediatrics. 1983 Apr;71(4):524–530. [PubMed] [Google Scholar]
  11. Meek S. R., Doberstyn E. B., Gaüzère B. A., Thanapanich C., Nordlander E., Phuphaisan S. Treatment of falciparum malaria with quinne and tetracycline or combined mefloquine/sulfadoxine/pyrimethamine on the Thai-Kampuchean border. Am J Trop Med Hyg. 1986 Mar;35(2):246–250. doi: 10.4269/ajtmh.1986.35.246. [DOI] [PubMed] [Google Scholar]
  12. Miller K. D., Lobel H. O., Satriale R. F., Kuritsky J. N., Stern R., Campbell C. C. Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis. Am J Trop Med Hyg. 1986 May;35(3):451–458. doi: 10.4269/ajtmh.1986.35.451. [DOI] [PubMed] [Google Scholar]
  13. Muto T., Ebisawa I., Mitsui G. Malaria in Laos. II. Peripheral leucocyte counts during long-term administration of combined folic inhibitors (pyrimethamine with sulformethoxine or sulfamonomethoxine). Jpn J Exp Med. 1971 Oct;41(5):459–470. [PubMed] [Google Scholar]
  14. Pang L. W., Limsomwong N., Boudreau E. F., Singharaj P. Doxycycline prophylaxis for falciparum malaria. Lancet. 1987 May 23;1(8543):1161–1164. doi: 10.1016/s0140-6736(87)92141-6. [DOI] [PubMed] [Google Scholar]
  15. Pearlman E. J., Doberstyn E. B., Sudsok S., Thiemanun W., Kennedy R. S., Canfield C. J. Chemosuppressive field trials in Thailand. IV. The suppression of Plasmodium falciparum and Plasmodium vivax parasitemias by mefloquine (WR 142,490, A 4-quinolinemethanol). Am J Trop Med Hyg. 1980 Nov;29(6):1131–1137. [PubMed] [Google Scholar]
  16. Peto T. E., Gilks C. F. Strategies for the prevention of malaria in travellers: comparison of drug regimens by means of risk-benefit analysis. Lancet. 1986 May 31;1(8492):1256–1261. doi: 10.1016/s0140-6736(86)91395-4. [DOI] [PubMed] [Google Scholar]
  17. Varsano I., Volovitz B., Mimouni F. Sulfisoxazole prophylaxis of middle ear effusion and recurrent acute otitis media. Am J Dis Child. 1985 Jun;139(6):632–635. doi: 10.1001/archpedi.1985.02140080102044. [DOI] [PubMed] [Google Scholar]
  18. Win K., Thwe Y., Lwin T. T., Win K. Combination of mefloquine with sulfadoxine-pyrimethamine compared with two sulfadoxine-pyrimethamine combinations in malaria chemoprophylaxis. Lancet. 1985 Sep 28;2(8457):694–695. doi: 10.1016/s0140-6736(85)92933-2. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES